MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $260 | -12.5% | 33,011 | +157.7% | 0.00% | 0.0% |
Q2 2023 | $297 | -0.3% | 12,811 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $298 | +60.2% | 12,811 | 0.0% | 0.00% | +100.0% |
Q4 2022 | $186 | -99.9% | 12,811 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $244,000 | +4.7% | 12,811 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $233,000 | -27.9% | 12,811 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $323,000 | -8.8% | 12,811 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $354,000 | -14.5% | 12,811 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $414,000 | +5.6% | 12,811 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $392,000 | +0.5% | 12,811 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $390,000 | +54.2% | 12,811 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $253,000 | +51.5% | 12,811 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $167,000 | +15.2% | 12,811 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $145,000 | -20.8% | 12,811 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $183,000 | -47.6% | 12,811 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $349,000 | -4.9% | 12,811 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $367,000 | +3.1% | 12,811 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $356,000 | -16.2% | 12,811 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $425,000 | +14.2% | 12,811 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $372,000 | -36.8% | 12,811 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $589,000 | +23.0% | 12,811 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $479,000 | +26.4% | 12,811 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $379,000 | -14.1% | 12,811 | -0.3% | 0.00% | 0.0% |
Q4 2017 | $441,000 | -5.2% | 12,854 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $465,000 | +35.2% | 12,854 | -3.3% | 0.00% | 0.0% |
Q2 2017 | $344,000 | +34.9% | 13,295 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $255,000 | +6.7% | 13,295 | -7.1% | 0.00% | 0.0% |
Q4 2016 | $239,000 | -20.9% | 14,314 | -2.4% | 0.00% | 0.0% |
Q3 2016 | $302,000 | -32.7% | 14,673 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $449,000 | -19.8% | 14,673 | -1.9% | 0.00% | -20.0% |
Q1 2016 | $560,000 | -22.1% | 14,963 | -10.2% | 0.01% | -16.7% |
Q4 2015 | $719,000 | +15.0% | 16,666 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $625,000 | +10.4% | 16,666 | 0.0% | 0.01% | +20.0% |
Q2 2015 | $566,000 | -25.7% | 16,666 | -22.6% | 0.01% | -16.7% |
Q1 2015 | $762,000 | +4.2% | 21,521 | +0.3% | 0.01% | 0.0% |
Q4 2014 | $731,000 | -11.8% | 21,461 | -0.2% | 0.01% | -14.3% |
Q3 2014 | $829,000 | -1.1% | 21,502 | -0.1% | 0.01% | 0.0% |
Q2 2014 | $838,000 | -2.0% | 21,525 | -13.9% | 0.01% | 0.0% |
Q1 2014 | $855,000 | +41.8% | 24,996 | -13.0% | 0.01% | +40.0% |
Q4 2013 | $603,000 | -84.5% | 28,739 | -82.6% | 0.01% | -86.1% |
Q3 2013 | $3,888,000 | -12.6% | 165,448 | -0.0% | 0.04% | -14.3% |
Q2 2013 | $4,447,000 | – | 165,507 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |